Break it Down: Archer innovativing at-home kidney check
Two medical companies have formed a strategic partnership to create an at-home kidney disease diagnostic test.
Archer Materials (ASX:AXE) is partnering with Hylid Diagnostics to develop an at home kidney disease testing kit for patients.
Leveraging Hylid’s expertise in blood hemolysis sensors and Archer's potassium sensing technology, the dynamic duo hopes to make a real impact for patients struggling with chronic kidney disease.
Watch the video to find out more.
Originally published as Break it Down: Archer innovativing at-home kidney check
Gold drill hits that lit up in the March quarter
As prices climb higher gold explorers are drilling for more. These 20 companies delivered highlight gold hits in the March quarter.
Clinuvel highlights the gap between biotech’s cash have-nots and have-lots
With $200 million of cash on hand, Clinuvel’s financial position is the envy of other biotechs. But not everyone is happy.
Will silver ever be the star debutante?
With demand growing and exceeding supply, analysts believe elevated silver prices have more room to run.